Media

The Neuron Clinic Launches New Alzheimer’s & Dementia Center Powered by Positrigo’s NeuroLF® Brain PET System

Aprea Therapeutics Announces $3.1 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Hemab Therapeutics Announces Positive Complete Phase 2 Data for Sutacimig in Glanzmann Thrombasthenia at ASH 2025; Plans to Advance to Pivotal Phase 3 Study

Vicore to present at the Oppenheimer Movers in Rare Disease Summit

HelloBetter launches Ello, a personal AI companion

Intervacc – Interim report January – September 2025

Vicore Pharma announces successful execution of a directed share issue of approximately USD 48 million (approximately SEK 455 million)

Aprea Therapeutics Reports Third quarter 2025 Financial Results and Provides a Clinical Update

Ariceum Therapeutics Doses First Patient in SANTANA-225 Phase 1/2 Clinical Trial of 225Ac-SSO110 in Patients with Extensive-Stage Small Cell Lung Cancer or Merkel Cell Carcinoma

Oncopeptides – Annals of Hematology: Expert consensus supports use of Pepaxti in myeloma